secwatch.observer — SEC 8-K summary
======================================

Issuer:     Decoy Therapeutics Inc. (DCOY)
CIK:        0001615219
Form:       8-K
Filed at:   2024-08-14T23:59:59+00:00
Accession:  0001615219-24-000073
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Salarius files ATM offering prospectus supplement for up to $335,921 in common stock
--------------------------------------------------------------------------------

- Filed Prospectus Supplement on July 25, 2024 for at-the-market offering of up to $335,921 of common stock.
- Offering conducted under prior S-3 registration statement (File No. 333-266589) declared effective August 16, 2022.
- ATM agreement dated February 5, 2021 with Ladenburg Thalmann & Co. Inc. as sales agent.
- Legal opinion of Hogan Lovells US LLP on share validity filed as Exhibit 5.1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1615219/000161521924000073/0001615219-24-000073-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1615219/000161521924000073/flks-20240813.htm
  HTML page:      https://secwatch.observer/filing/0001615219-24-000073

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer